Skip to content

Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection

Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection: A Randomized Controlled Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06202222
Acronym
IRPOL
Enrollment
184
Registered
2024-01-11
Start date
2024-09-09
Completion date
2027-05-09
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

For patients diagnosed with non-small cell lung cancer (NSCLC), lung resection surgery remains the gold standard for curative treatment. This scheduled operation is associated with significant morbidity, particularly in individuals with impaired cardio-respiratory function. Therefore, patient optimization is paramount. The process begins prior to surgery with preoperative rehabilitation, commonly referred to as prehabilitation, serving as the foundation for various Enhanced Recovery After Surgery programs. The training methods employed in these programs bear similarity to rehabilitation programs designed for patients with chronic obstructive pulmonary disease (COPD). Postoperatively, patients undergoing thoracic surgery partake in daily physiotherapy sessions, aiming to optimize the postoperative period, minimize the respiratory impact of surgery, and reduce the length of hospital stay. However, this treatment is not currently standardized and primarily involves early mobilization, including walking, and respiratory physiotherapy. Our focus is on the intensity and methods of this postoperative rehabilitation. There is limited literature on effective early rehabilitation in the immediate postoperative period, and existing studies suggest no adverse events associated with postoperative training. Therefore, our objective is to assess whether combining endurance training with standard physiotherapy (walking and respiratory physiotherapy) enhances the functional capacity of individuals undergoing lung surgery.

Interventions

OTHERrehabilitation

The patient undergoes a daily session on the cycloergometer (Am3i Ergometer). The patient is instructed to pedal at a heart rate ranging from 60% to 80% of their maximum heart rate (calculated as 220 minus their age) for a duration of 20 minutes. These sessions can be conducted with oxygen therapy for patients dependent on oxygen. The sessions are maintained until the patient is discharged from the department.

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients requiring surgery for diagnosed or undergoing diagnosis of lung cancer. * Patients in need of major lung resection through a minimally invasive approach. * Patients capable of performing the chair rise test.

Exclusion criteria

\- Contraindications to cyclo-ergometry: Deep vein thrombosis in a lower limb. Patients with one or both lower limbs amputated. Rheumatological pathology, trauma, or previous surgery in the lower limb, pelvis, or spine, resulting in limited joint amplitude or strict immobilization. Dermatological conditions with severe lesions preventing prolonged sitting on a bicycle. * Glasgow score less than 15. * Patients who have not undergone pulmonary resection by minimally invasive surgery. * Patients hospitalized outside the thoracic surgery department before the first post-operative visit with the physiotherapist on Day 0.

Design outcomes

Primary

MeasureTime frameDescription
Number of chair lifts at the scheduled visit 30 days after surgery30 days after surgerynumber of chair lifts

Secondary

MeasureTime frame
number of days between surgery and discharge patient30 days after surgery
chair rise test7 days after surgery
number of complication GRADE II of clavien dindo classification30 days after surgery

Countries

France

Contacts

Primary ContactJean-Marc BASTE, PhD
jean-marc.baste@chu-rouen.fr+33 2 32 88 87 04
Backup ContactFairuz BOUJIBAR, PhD
fairuz.biujibar@chu-rouen.fr+33 2 32 88 89 90

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026